Skip to content

Ondancetron Effect at Vomiting Control in Head Trauma

Comparing the Antiemetic Effects of Ondansetron and Metoclopramide in Patients with Minor Head Trauma

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015043012072N6
Enrollment
120
Registered
2015-05-24
Start date
2014-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: head Injuries. Condition 2: head Injuries. Intracranial injury, unspecified Unspecified injury of head

Interventions

Intervention 1: Intervention group treat with ondansetron (4mg/2ml, slow injection). 20 minutes post drug administration, nausea level will measure again. If the severity of nausea not decrease at lea
Treatment - Drugs
Intervention group treat with ondansetron (4mg/2ml, slow injection). 20 minutes post drug administration, nausea level will measure again. If the severity of nausea not decrease at least by 20 mm comp
Cotrol group treat with metoclopramide (10mg/2ml, slow injection) and treatment with ondansetron (4mg/2ml, slow injection). 20 minutes post drug administration, nausea level will measure again.

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : minor head trauma; nausea and vomiting; and a triage level of 3 or higher based on emergency severity score; exclusion criteria : hemodynamic instability; pregnancy/lactation; any neurologic deficit; restlessleg syndrome; alcohol usage; consumption of any antiemetic drugs during the 8 hours prior to admission; chemotherapy or radiotherapy; inability to complete and understand study explanations or outcome measures; allergy or previous adverse reactions to metoclopramide or ondansetron;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nausea Severity. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Dystonia. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Physical Examination.;Fatigue. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Physical Examination.;Headache. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Visual AnalogueScale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Esmailian

Isfahan University of Medical Sciences

m_esmailian@med.mui.ac.ir+98 31 3629 3482

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026